Absci Corporation (ABSI)
USD 3.09
(2.32%)
USD 3.09
(2.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -41.84 Million USD | -13.59% |
| 2022 | -7.29 Million USD | -289.42% |
| 2021 | -1.87 Million USD | 71.93% |
| 2020 | -6.66 Million USD | -196.22% |
| 2019 | -2.25 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2.51 Million USD | 19.96% |
| 2024 Q2 | -2.11 Million USD | 16.04% |
| 2023 Q2 | -131 Thousand USD | 94.14% |
| 2023 FY | -8.28 Million USD | -13.59% |
| 2023 Q3 | -2.76 Million USD | -2013.74% |
| 2023 Q1 | -2.23 Million USD | -10.15% |
| 2023 Q4 | -3.14 Million USD | -13.62% |
| 2022 Q2 | -2.13 Million USD | -2.49% |
| 2022 Q1 | -2.08 Million USD | 59.88% |
| 2022 FY | -7.29 Million USD | -289.42% |
| 2022 Q4 | -2.02 Million USD | -96.04% |
| 2022 Q3 | -1.03 Million USD | 51.61% |
| 2021 FY | -1.87 Million USD | 71.93% |
| 2021 Q4 | -5.2 Million USD | 43.4% |
| 2021 Q3 | -9.19 Million USD | 10.87% |
| 2021 Q1 | -5.98 Million USD | -220.33% |
| 2021 Q2 | -10.31 Million USD | -72.24% |
| 2020 Q1 | -1.33 Million USD | 0.0% |
| 2020 FY | -6.66 Million USD | -196.22% |
| 2020 Q4 | -1.86 Million USD | -5.24% |
| 2020 Q3 | -1.77 Million USD | -5.21% |
| 2020 Q2 | -1.68 Million USD | -26.44% |
| 2019 FY | -2.25 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | 129.975% |
| Immix Biopharma, Inc. | -5468.00 USD | -765243.819% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -6202.56% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 46.069% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -7840.987% |
| MiMedx Group, Inc. | 266.84 Million USD | 115.683% |
| Novavax, Inc. | 639.93 Million USD | 106.54% |
| Seer, Inc. | 7.02 Million USD | 695.546% |
| Acelyrin, Inc. | -115 Thousand USD | -36290.435% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 130.938% |
| IO Biotech, Inc. | -756 Thousand USD | -5435.582% |
| Ardelyx, Inc. | 106.66 Million USD | 139.236% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 56.834% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -34.271% |
| Fortress Biotech, Inc. | 57.85 Million USD | 172.337% |
| Fortress Biotech, Inc. | 57.85 Million USD | 172.337% |
| Geron Corporation | -123.5 Million USD | 66.115% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 117.384% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 352.452% |
| Incyte Corporation | 3.44 Billion USD | 101.216% |
| Innoviva, Inc. | 261.06 Million USD | 116.03% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -75989.091% |
| ChromaDex Corporation | 50.78 Million USD | 182.412% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 134.946% |
| MEI Pharma, Inc. | 49.32 Million USD | 184.84% |
| NextCure, Inc. | -3.68 Million USD | -1035.966% |
| Onconetix, Inc. | -1.12 Million USD | -3612.766% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -44.466% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -29103.565% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 60.566% |
| Vaxcyte, Inc. | -75 Million USD | 44.201% |
| Precigen, Inc. | 106 Thousand USD | 39580.189% |
| Pharming Group N.V. | 220.1 Million USD | 119.013% |
| ContextLogic Inc. | 59 Million USD | 170.931% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -17938.362% |
| Pyxis Oncology, Inc. | -2 Million USD | -1992.45% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 138.124% |
| AlloVir, Inc. | -398 Thousand USD | -10414.824% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 244.034% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -416266.531% |
| Summit Therapeutics Inc. | -2.05 Million USD | -1941.415% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -348641.667% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -7229.072% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1459.784% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 34974.167% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -772.218% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 243.668% |
| Psyence Biomedical Ltd. | -240.00 USD | -17436983.333% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -94606.708% |
| Chimerix, Inc. | 324 Thousand USD | 13016.358% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -72901.779% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -50935.366% |
| CRISPR Therapeutics AG | 240.95 Million USD | 117.368% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 140.201% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 8226.019% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 4247.572% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1033.505% |
| Precision BioSciences, Inc. | 40.47 Million USD | 203.402% |
| Dyadic International, Inc. | 922.95 Thousand USD | 4634.231% |
| Elevation Oncology, Inc. | -39 Thousand USD | -107205.128% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 298.704% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 134.737% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 102.757% |
| Aptorum Group Limited | -1.11 Million USD | -3654.324% |
| Bicycle Therapeutics plc | -129.52 Million USD | 67.689% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -961.606% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 631.686% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -213.291% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Alkermes plc | 1.37 Billion USD | 103.044% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1055.893% |
| Jaguar Health, Inc. | 7.72 Million USD | 641.805% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 8537.298% |
| AbCellera Biologics Inc. | 38.02 Million USD | 210.057% |
| PureTech Health plc | -1.6 Million USD | -2510.667% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -7998.563% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 7.669% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 5318.08% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 294.24% |
| AnaptysBio, Inc. | 14.78 Million USD | 383.127% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -82.595% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -35218.294% |
| Molecular Templates, Inc. | 50.39 Million USD | 183.042% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 242.407% |
| Vaxxinity, Inc. | -2.23 Million USD | -1773.277% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -8405.894% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -90.335% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 10.654% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -4308.991% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -836880.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1133.054% |
| ImmuCell Corporation | 4.39 Million USD | 1051.918% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -23835.188% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 9970.047% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 319.761% |
| Opthea Limited | 21.72 Thousand USD | 192774.954% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 76.931% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 57.391% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 57.368% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 6971.757% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 113.342% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1725.835% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -82377.335% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -489.589% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -8718.763% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -402294.231% |
| Soligenix, Inc. | 97.31 Thousand USD | 43105.416% |
| Century Therapeutics, Inc. | -10.8 Million USD | -287.168% |
| Kura Oncology, Inc. | -849 Thousand USD | -4829.211% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 37.636% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -28368.707% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 142.255% |
| Autolus Therapeutics plc | -4.86 Million USD | -759.852% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 201.119% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -24810.119% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 144.18% |
| GRI Bio, Inc. | 10.84 Million USD | 486.025% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1747.608% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -381.743% |
| IGM Biosciences, Inc. | -211.66 Million USD | 80.228% |
| INmune Bio, Inc. | 155 Thousand USD | 27099.355% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 167.565% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2678.281% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6353.657% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -142856.207% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 10510.199% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -1996.643% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -13270.288% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 144.303% |
| Verastem, Inc. | -62 Thousand USD | -67398.387% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1818.645% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -15934.1% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1482.524% |
| Histogen Inc. | 3.76 Million USD | 1210.348% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 7363.194% |
| Surrozen, Inc. | -27.23 Million USD | -53.687% |
| Organovo Holdings, Inc. | -5.38 Million USD | -676.563% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3373.292% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -63.173% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 308.702% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2113485.859% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 789.846% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -62239.307% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 127.036% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 28803.018% |
| Apollomics, Inc. | 127 Thousand USD | 33051.969% |
| Amarin Corporation plc | 165.54 Million USD | 125.28% |
| Mesoblast Limited | -9.81 Million USD | -326.378% |
| Turnstone Biologics Corp. | 16.5 Million USD | 353.538% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 62.124% |
| Synaptogenix, Inc. | -6347.00 USD | -659250.874% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -81956.863% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 125.934% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 102.381% |
| Better Therapeutics, Inc. | -2.72 Million USD | -1433.492% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 62.688% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 112.378% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -366739.06% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -568.514% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3676.986% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 671.864% |
| Insmed Incorporated | 239.63 Million USD | 117.464% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 1269.62% |
| OmniAb, Inc. | 14.66 Million USD | 385.328% |
| Alector, Inc. | -95.05 Million USD | 55.973% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 133.314% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 3.714% |
| Zai Lab Limited | 170.9 Million USD | 124.487% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 151.112% |
| Aura Biosciences, Inc. | -1.29 Million USD | -3131.583% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 32291.538% |
| Immunic, Inc. | -111 Thousand USD | -37601.802% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 363.965% |
| Veracyte, Inc. | 248.14 Million USD | 116.865% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.401% |
| FibroGen, Inc. | 128.9 Million USD | 132.465% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -7419935.461% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -258.699% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.231% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 10858.098% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 111.777% |
| TG Therapeutics, Inc. | 219.1 Million USD | 119.1% |
| Galecto, Inc. | -830 Thousand USD | -4942.048% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -2921.588% |
| Fortrea Holdings Inc. | 424 Million USD | 109.87% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 51.433% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -7280.776% |
| XBiotech Inc. | -1.74 Million USD | -2299.599% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3676.986% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 9.946% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 44.596% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 157.013% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 349.057% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 110.757% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 15.707% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 112.808% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -269.565% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 271.155% |
| NexImmune, Inc. | -1.02 Million USD | -3982.941% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 775081.481% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -488.953% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.37% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -62522.892% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1078.513% |
| Ainos, Inc. | -253.73 Thousand USD | -16393.322% |
| Pluri Inc. | 322 Thousand USD | 13096.584% |
| Prothena Corporation plc | -129.2 Million USD | 67.609% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 182.994% |
| Celularity Inc. | 6.75 Million USD | 719.526% |
| Rallybio Corporation | -150 Thousand USD | -27799.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -28.344% |
| MeiraGTx Holdings plc | 287 Thousand USD | 14681.533% |
| Omeros Corporation | -69.77 Million USD | 40.026% |
| Humacyte, Inc. | -76.55 Million USD | 45.331% |
| Immunocore Holdings plc | 248.39 Million USD | 116.848% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -175.885% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 167.085% |
| Blueprint Medicines Corporation | 236.58 Million USD | 117.689% |
| CalciMedica, Inc. | -58 Thousand USD | -72053.448% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -2834.712% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1371.484% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -35.587% |
| Pulmatrix, Inc. | -8.22 Million USD | -409.112% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3476.838% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -10388.471% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 89.506% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1607.754% |
| Cytokinetics, Incorporated | -322.59 Million USD | 87.027% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 4954.281% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -12172.434% |
| Vor Biopharma Inc. | -3.49 Million USD | -1098.425% |
| Roivant Sciences Ltd. | 109.23 Million USD | 138.311% |
| Evogene Ltd. | 1.39 Million USD | 3091.351% |
| ProKidney Corp. | -3.16 Million USD | -1220.574% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4.698% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 710.311% |
| CorMedix Inc. | -205.56 Thousand USD | -20258.335% |
| BioLineRx Ltd. | 1.1 Million USD | 3876.986% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 46.805% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -126715.152% |
| Atai Life Sciences N.V. | -5000.00 USD | -836880.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -34242.15% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -43492.708% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -2912.887% |
| Sagimet Biosciences Inc. | 2 Million USD | 2192.45% |
| MediciNova, Inc. | 979.7 Thousand USD | 4371.592% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 50.368% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -44158.897% |
| GeoVax Labs, Inc. | -20.72 Million USD | -101.966% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 117.114% |
| Biomea Fusion, Inc. | -4.2 Million USD | -896.168% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 104.797% |
| Mereo BioPharma Group plc | 7.42 Million USD | 663.547% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -13399.677% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -836880.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 45.204% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1600.488% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 119.58% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -4347.29% |
| Allakos Inc. | -6.14 Million USD | -581.469% |
| Imunon, Inc. | -720 Thousand USD | -5712.321% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 39.346% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 108.794% |
| BioAtla, Inc. | -103.73 Million USD | 59.656% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -366739.06% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -23410.674% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 82.765% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -13356.27% |
| XOMA Corporation | 3.86 Million USD | 1183.89% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 40.288% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 382.878% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1652.471% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 435.867% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -144206.897% |
| Viridian Therapeutics, Inc. | -1 Million USD | -4051.687% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 321915484.615% |
| Akari Therapeutics, Plc | -4000.00 USD | -1046125.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 106.571% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 21593.21% |
| UroGen Pharma Ltd. | 73.35 Million USD | 157.052% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -56.773% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 360556.503% |
| Orgenesis Inc. | -5.72 Million USD | -630.987% |
| Entera Bio Ltd. | -56 Thousand USD | -74630.357% |
| GH Research PLC | -315 Thousand USD | -13185.397% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -22042.328% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -7871.238% |
| Xencor, Inc. | -85.26 Million USD | 50.916% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -18838.17% |
| Replimune Group, Inc. | -2.65 Million USD | -1476.234% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -4079.734% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 123.531% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 21593.21% |
| Portage Biotech Inc. | -54 Thousand USD | -77398.148% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -44158.897% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -11000.531% |
| OncoCyte Corporation | 413 Thousand USD | 10232.93% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -930912.236% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -18850800.901% |
| Purple Biotech Ltd. | -196 Thousand USD | -21251.531% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 566.648% |
| scPharmaceuticals Inc. | 9.78 Million USD | 527.816% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -300.662% |
| HilleVax, Inc. | -2.15 Million USD | -1841.048% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -43043.299% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -278818.955% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -6164.82% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -181852.174% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -557428.75% |
| Savara Inc. | -44.26 Million USD | 5.452% |
| Curis, Inc. | 9.81 Million USD | 526.552% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1611.055% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -33436.077% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2320.416% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -18254.825% |
| BeiGene, Ltd. | 2.07 Billion USD | 102.013% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -1396.799% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 89.529% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 173.823% |
| Erasca, Inc. | -3.73 Million USD | -1021.356% |
| bluebird bio, Inc. | -4.03 Million USD | -938.437% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -148206.046% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.198% |
| DBV Technologies S.A. | 15.72 Million USD | 366.08% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -148206.046% |
| Moderna, Inc. | 2.15 Billion USD | 101.942% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4473.661% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 622.72% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -7707.649% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 131.28% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -572.597% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -6.37% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 62.342% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1066.36% |
| MacroGenics, Inc. | 50.52 Million USD | 182.825% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -586.274% |
| Prime Medicine, Inc. | -147.9 Million USD | 71.705% |
| Aditxt, Inc. | -111.66 Thousand USD | -37378.954% |
| Adagene Inc. | 18.11 Million USD | 331.063% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 8675.615% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 129.849% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 126.514% |
| SciSparc Ltd. | 2.19 Million USD | 2005.692% |
| Vericel Corporation | 135.57 Million USD | 130.868% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -166968.546% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -134975.205% |
| Generation Bio Co. | -73.91 Million USD | 43.379% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -9476.43% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 176.62% |
| Invivyd, Inc. | -2.02 Million USD | -1963.56% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 86.089% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -40358.052% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 143.426% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 142.578% |
| ADMA Biologics, Inc. | 88.21 Million USD | 147.438% |
| Clene Inc. | 533 Thousand USD | 7951.595% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 273.581% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -4272.936% |
| GeoVax Labs, Inc. | -20.72 Million USD | -101.966% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2205.08% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -21436.569% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 184.026% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -490.087% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -4905.861% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 150.17% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 57339.578% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 178.72% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 75.836% |
| Trevena, Inc. | 1.45 Million USD | 2976.22% |
| Surrozen, Inc. | -27.23 Million USD | -53.687% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -11755.241% |
| Cingulate Inc. | -582.91 Thousand USD | -7079.226% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -134896.774% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -112.442% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -552726.948% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -4650.17% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 106.148% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -4135.729% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -74176.738% |
| Kronos Bio, Inc. | 1.37 Million USD | 3150.219% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 22.02% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -14231.849% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -8470.1% |
| ImmunityBio, Inc. | -17.89 Million USD | -133.924% |
| Korro Bio, Inc. | -3.63 Million USD | -1052.865% |
| Kineta, Inc. | 5.43 Million USD | 870.274% |
| BioVie Inc. | -229.37 Thousand USD | -18144.637% |
| Codexis, Inc. | 57.33 Million USD | 172.992% |
| Celularity Inc. | 6.75 Million USD | 719.526% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1142.836% |
| Celcuity Inc. | -142.77 Thousand USD | -29211.77% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 82821.882% |
| Cibus, Inc. | 1.42 Million USD | 3042.968% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -11089.572% |
| IN8bio, Inc. | -2.5 Million USD | -1573.291% |
| Kodiak Sciences Inc. | -25.94 Million USD | -61.286% |
| Annexon, Inc. | -3.26 Million USD | -1180.961% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -1947.407% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -0.268% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 6638.906% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 105.375% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 124.196% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -2102.579% |
| Arcellx, Inc. | 108.27 Million USD | 138.649% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -29.287% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 152.837% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -97.849% |
| Moolec Science SA | -143.3 Thousand USD | -29102.749% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1.108% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1373.167% |
| Royalty Pharma plc | 1.79 Billion USD | 102.333% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 40.292% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1158510.188% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 18185.837% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 62.438% |
| Humacyte, Inc. | -76.55 Million USD | 45.331% |
| 89bio, Inc. | -273 Thousand USD | -15229.304% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -3229.276% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -4835.024% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -33923.577% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 3839.857% |
| Notable Labs, Ltd. | 113 Thousand USD | 37134.513% |
| Liquidia Corporation | 14.6 Million USD | 386.637% |
| Mustang Bio, Inc. | -2.22 Million USD | -1780.854% |
| Immunovant, Inc. | -231 Thousand USD | -18016.45% |
| Quantum-Si incorporated | 488 Thousand USD | 8675.615% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 24.676% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -139396.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2347.53% |
| Acasti Pharma Inc. | -11 Thousand USD | -380345.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -20352.357% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6353.657% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 75.017% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 3788.501% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -10883.99% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -2037.334% |
| PepGen Inc. | -1.18 Million USD | -3434.544% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -32851.969% |
| United Therapeutics Corporation | 2.07 Billion USD | 102.022% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -82.771% |
| Solid Biosciences Inc. | -76.56 Million USD | 45.34% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -50575.078% |
| Immuneering Corporation | -764.13 Thousand USD | -5376.629% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 63254.956% |
| Belite Bio, Inc | -399 Thousand USD | -10388.471% |
| XOMA Corporation | 3.86 Million USD | 1183.89% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -108.869% |
| Bionomics Limited | -434.44 Thousand USD | -9532.661% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3796.555% |
| uniQure N.V. | 2.21 Million USD | 1989.345% |
| Cassava Sciences, Inc. | -89.42 Million USD | 53.201% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 54.546% |
| Forte Biosciences, Inc. | -9000.00 USD | -464888.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -4911.856% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -9476.43% |
| Altimmune, Inc. | -65.37 Million USD | 35.984% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 111.56% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3796.555% |
| Compugen Ltd. | 31.45 Million USD | 233.044% |
| Peak Bio, Inc. | 367.76 Thousand USD | 11479.154% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 270.701% |
| Benitec Biopharma Inc. | 108 Thousand USD | 38849.074% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -53552.564% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3378.72% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -2196.872% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -35067.227% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3378.72% |
| Instil Bio, Inc. | -4.75 Million USD | -779.92% |
| argenx SE | 1.1 Billion USD | 103.775% |
| Immunome, Inc. | -8.9 Million USD | -369.844% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2114.233% |
| Verona Pharma plc | -679.62 Thousand USD | -6057.67% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -23813.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1654.675% |
| CervoMed Inc. | -1.29 Million USD | -3135.013% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1638.637% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -776.052% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1793.606% |
| Moolec Science SA | -143.3 Thousand USD | -29102.749% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -10156.354% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1466.482% |
| Design Therapeutics, Inc. | -537 Thousand USD | -7693.11% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -9700.703% |
| NeurAxis, Inc. | 2.15 Million USD | 2040.415% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2050.093% |
| Lumos Pharma, Inc. | 2 Million USD | 2185.152% |
| Achilles Therapeutics plc | -4.73 Million USD | -784.52% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -23813.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -39501.609% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 232.188% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 4954.281% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -3955.136% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 8.121% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 97423.256% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -4991.119% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -317949.856% |
| Palisade Bio, Inc. | 246 Thousand USD | 17111.789% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -126715.152% |
| Beam Therapeutics Inc. | -59.67 Million USD | 29.868% |
| Neurogene Inc. | -3.26 Million USD | -1182.925% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 130.035% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 204.623% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -13990.572% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -939.201% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -337.476% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 397.223% |
| Athira Pharma, Inc. | -969 Thousand USD | -4218.782% |
| Vaccinex, Inc. | -16 Million USD | -161.491% |
| HCW Biologics Inc. | -574.82 Thousand USD | -7180.315% |
| XOMA Corporation | 3.86 Million USD | 1183.89% |
| Nektar Therapeutics | 53.47 Million USD | 178.255% |
| Arvinas, Inc. | 71.8 Million USD | 158.286% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 49.858% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 33.335% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -12896.584% |
| Rezolute, Inc. | -36 Thousand USD | -116147.222% |
| Clene Inc. | 533 Thousand USD | 7951.595% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -3259167.913% |
| BeyondSpring Inc. | 1.75 Million USD | 2490.006% |
| Synlogic, Inc. | -1.92 Million USD | -2075.104% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -113005.405% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -560.913% |
| Peak Bio, Inc. | 367.76 Thousand USD | 11479.154% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -120.688% |
| Krystal Biotech, Inc. | 47.6 Million USD | 187.909% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 129.661% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 932.816% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1516.279% |
| MannKind Corporation | 136.19 Million USD | 130.728% |
| Ikena Oncology, Inc. | -50.49 Million USD | 17.118% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 138.459% |
| Gossamer Bio, Inc. | -4.38 Million USD | -854.367% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -16506.746% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -836880.0% |
| Legend Biotech Corporation | 140.92 Million USD | 129.695% |
| Mural Oncology plc | -2.56 Million USD | -1530.269% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -7495.1% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -41749.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 301.643% |
| REGENXBIO Inc. | 53.02 Million USD | 178.917% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -681.209% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -21653.866% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2316.224% |
| Vaxart, Inc. | -60.76 Million USD | 31.127% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -15825.489% |
| Cellectis S.A. | 18 Thousand USD | 232594.444% |
| Longeveron Inc. | 221 Thousand USD | 19036.199% |
| Repare Therapeutics Inc. | -80.07 Million USD | 47.734% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 103.829% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -3134.08% |
| Revolution Medicines, Inc. | -399.66 Million USD | 89.529% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -119468.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 85506.122% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.486% |
| Denali Therapeutics Inc. | -93.34 Million USD | 55.167% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -166968.546% |
| Veru Inc. | 7.56 Million USD | 653.124% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -27614.57% |
| Cingulate Inc. | -582.91 Thousand USD | -7079.226% |
| Passage Bio, Inc. | -3.72 Million USD | -1024.671% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -347367.619% |
| Exicure, Inc. | -1.42 Million USD | -2840.9% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -10826.632% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1648.243% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -8062.871% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 161.429% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -27872.622% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 29.316% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 10803.069% |
| OmniAb, Inc. | 14.66 Million USD | 385.328% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 309.318% |
| Lipocine Inc. | -2.85 Million USD | -1367.965% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2170.7% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -633.55% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2678.281% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 155.565% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -64283.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 149.645% |
| Ocugen, Inc. | -33.53 Million USD | -24.785% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1223.498% |
| Q32 Bio Inc. | 578 Thousand USD | 7340.311% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -15692.075% |
| Alumis Inc. Common Stock | -1.28 Million USD | -3159.268% |
| Equillium, Inc. | 35.95 Million USD | 216.383% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2351.611% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 8458.449% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1012212.53% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -16057.915% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 10000.121% |
| Dominari Holdings Inc. | 2.03 Million USD | 2152.428% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -22709.599% |
| vTv Therapeutics Inc. | -13.59 Million USD | -207.826% |
| Bio-Techne Corporation | 773.07 Million USD | 105.413% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 341.636% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 109.082% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3479.897% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -74.516% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 457.775% |
| Nkarta, Inc. | -5.86 Million USD | -613.052% |
| BioCardia, Inc. | -7.24 Million USD | -477.307% |
| Iterum Therapeutics plc | -1.75 Million USD | -2291.371% |